LYTS Form 144: Insider Sale of 54,575 Shares (~$1.27M)
LSI Industries (LYTS) insider filing: An individual reported the proposed sale of 54,575 common shares through Morgan Stanley Smith Barney on the NASDAQ, with an aggregate market value of $1,271,084.50.
Rhea-AI Filing Summary
LSI Industries (LYTS) insider filing: An individual reported the proposed sale of 54,575 common shares through Morgan Stanley Smith Barney on the NASDAQ, with an aggregate market value of $1,271,084.50. The shares were acquired and are proposed to be sold on 09/08/2025 following a stock option exercise, with cash used to pay the option consideration.
The filer disclosed prior sales by the same person: 18,345 shares sold on 08/27/2025 for $419,515.08. The company has 30,004,460 shares outstanding. The filer certified they are not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR Routine insider sale of exercised options; size is small relative to total shares outstanding and appears non-material.
The filing shows an insider exercising options and immediately proposing to sell 54,575 shares valued at $1.27M. Relative to the issuer's reported 30,004,460 shares outstanding, this sale represents roughly 0.18% of the float, indicating limited dilution or market impact. The immediate cash payment for the exercise and use of a brokered sale are consistent with typical option-exercise monetization. Prior sale of 18,345 shares on 08/27/2025 is disclosed, suggesting ongoing, routine monetization rather than a single large exit.
TL;DR Disclosure aligns with Rule 144 mechanics; representation on material non-disclosure is standard and important.
The filer completed required Rule 144 reporting: stating acquisition details (stock option exercise), sale method (broker-dealer), and affirming no undisclosed material adverse information. The signature declaration warns about criminal penalties for misstatements, highlighting governance safeguards. There is no indication in the filing of unusual timing, related-party transfers, or restricted securities anomalies—this appears to be a standard compliance disclosure for an exercised-option sale.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the LYTS Form 144 report disclose about the transaction?
How much is the proposed sale worth according to the LYTS filing?
When were the securities acquired and how was the exercise paid?
AI-generated analysis. How Rhea-AI works. Not financial advice.